|
|
||||||||
Klinikum der Universität Heidelberg, Heidelberg, FRG
Correspondence: For reprints contact: Dr. Ds. B. Kimmig, Klinikum der Universität Heidelberg, Zentrum Radiologie, Abt. Für Klimische Nuklearmedizin, Voßstr. 3. 6900 Heidelberg, FRG.
ABSTRACT
Radioiodinated m-iodobenzylguanidine has been applied mainly for the diagnosis of pheochromocytoma and blastoma. In this paper we show that an ontogenetically related tumor, the neuroblastoma, is also scintigraphically visualized by its high uptake of I-131 MIBG. Because of the kinetic findings and the high uptake of more than 30% of the injected activity, it is likely that the neuroblastoma, by analogy with pheochromocytoma, is susceptible to specific radionuclide therapy.
This article has been cited by other articles:
![]() |
S. MELLER Targeted radiotherapy for neuroblastoma Arch. Dis. Child., November 1, 1997; 77(5): 389 - 392. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |